Teva rolls out dollars while paving the way for euros
Teva, the Israeli-American pharmaceutical company, has begun the dollar portion of a multi-tranche bond financing of its acquisition of Allergan's generic drugs business, with euro tranches due to follow soon.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts